Unit 9: RNA viruses (part 3)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/113

encourage image

There's no tags or description

Looks like no tags are added yet.

114 Terms

1
New cards

What are the main characteristics of Picornaviridae?

Small, non-enveloped, single-stranded RNA (ssRNA) viruses, approximately 30 nm in diameter.

2
New cards

What proteins make up the picornavirus capsid?

Four viral proteins: VP1, VP2, VP3, and VP4.

3
New cards

Which three genera of Picornaviridae are clinically significant in humans?

Enterovirus, Hepatovirus, and Parechovirus.

4
New cards

Which important viruses belong to the genus Enterovirus?

Rhinoviruses, polioviruses, coxsackieviruses, echoviruses, and other enteroviruses.

5
New cards

Which virus belongs to the genus Hepatovirus?

Hepatitis A virus (HAV).

6
New cards

What genus do rhinoviruses belong to?

Enterovirus, within the family Picornaviridae.

7
New cards

What are the three rhinovirus species?

Rhinovirus A, B, and C, with more than 150 serotypes.

8
New cards

What is the most common viral cause of the common cold?

Rhinoviruses, responsible for approximately 50–70% of common colds

9
New cards

How are rhinoviruses transmitted?

Through respiratory aerosols/droplets or contact with contaminated respiratory secretions via hands and fomites.

10
New cards

What is the incubation period of rhinovirus infection?

Approximately 2 days

11
New cards

What are the typical symptoms of rhinovirus infection?

Rhinorrhea (runny nose), nasal congestion, sneezing, sore throat, cough, headache, fever, and malaise.

12
New cards

How long does a typical rhinovirus infection last?

Usually resolves within 1–2 weeks

13
New cards

What is a common complication of rhinovirus infection in children?

Otitis media (middle ear infection), associated with approximately one-third of pediatric HRV infections

14
New cards

What lower respiratory tract complications can rhinoviruses cause?

Bronchiolitis, bronchitis, and pneumonia.

15
New cards

Which chronic respiratory diseases can rhinovirus infections exacerbate?

Asthma and chronic obstructive pulmonary disease (COPD).

16
New cards

Is laboratory testing routinely necessary for rhinovirus infections?

No. Testing is generally not indicated for uncomplicated infections.

17
New cards

How can rhinovirus infection be diagnosed when laboratory testing is needed?

RT-qPCR on a nasopharyngeal (NP) swab or bronchoalveolar lavage (BAL) specimen.

18
New cards

When and where do rhinoviruses circulate?

Worldwide throughout the year, with peaks in early fall and spring

19
New cards

How are rhinovirus infections prevented?

Handwashing, isolating when sick, and disinfecting contaminated objects and surfaces.

20
New cards

What is the treatment for rhinovirus infection?

Supportive treatment to relieve symptoms; no specific antiviral treatment

21
New cards

What are non-polio enteroviruses?

Members of the genus Enterovirus that are not associated with poliomyelitis

22
New cards

What three major groups of non-polio enteroviruses are discussed?

Coxsackieviruses, other enteroviruses, and echoviruses.

23
New cards

What are the two major groups of coxsackieviruses?

Coxsackievirus A (CV-A) and Coxsackievirus B (CV-B)

24
New cards

How many coxsackievirus A and B serotypes are listed?

  • CV-A: 24 serotypes (A1–A24)

  • CV-B: 6 serotypes (B1–B6).


25
New cards

How are coxsackievirus serotypes distinguished?

By antigenic differences.

26
New cards

Which two examples of non-polio enteroviruses are specifically mentioned?

EV-A71 and EV-D68.

27
New cards

How many echovirus serotypes are listed?

33 serotypes (E-1 through E-33).

28
New cards

Where do non-polio enteroviruses initially infect and replicate?

In epithelial cells of the pharynx and gastrointestinal (GI) tract.

29
New cards

What are the main routes of non-polio enterovirus transmission?

Respiratory transmission through aerosols/droplets or contaminated hands/fomites, and enteric transmission through the fecal–oral route.

30
New cards

What is viremia, and why is it important in non-polio enterovirus infections?

Viremia is the presence of virus in the bloodstream, allowing infection to spread to different organs.

31
New cards

What determines the severity of a non-polio enterovirus infection?

The infecting virus, the organs to which it spreads, and the host's immune status.

32
New cards

What is the major difference between rhinovirus and non-polio enterovirus infections emphasized in these slides?

Rhinoviruses primarily cause respiratory infections, while non-polio enteroviruses can initially infect the pharynx or GI tract and spread through viremia to other organs.

33
New cards

What is the most common cause of hand, foot, and mouth disease (HFMD) in the United States?

Coxsackievirus A16 (CV-A16). Other causes include CV-A6 and EV-A71.

34
New cards

Which age group is most commonly affected by hand, foot, and mouth disease (HFMD)?

Children under 5 years old.

35
New cards

What are the characteristic symptoms of hand, foot, and mouth disease (HFMD)?

Fever, sore throat, malaise, irritability, painful blisters inside the mouth and on the tongue, and a rash on the palms and soles

36
New cards

Where else can the rash associated with HFMD appear?

Around the mouth, nose, legs, and arms

37
New cards

How long does hand, foot, and mouth disease typically last?

Approximately 7–10 days

38
New cards

What eye infection can non-polio enteroviruses cause?

Conjunctivitis (pink eye).

39
New cards

What mild respiratory illness can non-polio enteroviruses cause?

The common cold, with symptoms ranging from mild to severe influenza-like illness.

40
New cards

Which non-polio enteroviruses are particularly associated with myocarditis and pericarditis?

Coxsackieviruses.

41
New cards

What is the difference between myocarditis and pericarditis?

Myocarditis is inflammation of the heart muscle, while pericarditis is inflammation of the membrane surrounding the heart.

42
New cards

What serious central nervous system infections can non-polio enteroviruses cause?

Viral (aseptic) meningitis and encephalitis. The lecture identifies enteroviruses as the most common cause of viral meningitis.

43
New cards

Which non-polio enterovirus is associated with acute flaccid myelitis (AFM)?

Enterovirus D68 (EV-D68).

44
New cards

What is acute flaccid myelitis (AFM), and what are its symptoms?

A neurological condition affecting the spinal cord that causes sudden arm or leg weakness, loss of muscle tone, and sometimes difficulty breathing.

45
New cards

Is laboratory testing routinely required for non-polio enterovirus infections?

No. Testing is generally unnecessary for uncomplicated infections, but may be needed in severe cases.

46
New cards

What is the preferred diagnostic method for non-polio enterovirus infections?

RT-qPCR.

47
New cards

What specimens can be collected to diagnose non-polio enterovirus infections?

Nasopharyngeal (NP), throat, rectal, or vesicle swabs, as well as cerebrospinal fluid (CSF) or pericardial fluid.

48
New cards

How are non-polio enterovirus infections prevented and treated?

Handwashing, isolation when sick, and disinfecting contaminated surfaces. There are no specific antivirals listed in the lecture; treatment is supportive.

49
New cards

How many poliovirus serotypes exist?

Three: PV1, PV2, and PV3.

50
New cards

How does poliovirus enter the body, and where does it initially replicate?

It enters through the mouth and replicates in the pharynx and gastrointestinal (GI) tract.

51
New cards

How long can poliovirus be shed, and can asymptomatic individuals transmit it?

Poliovirus can be present in nasopharyngeal secretions for 1–2 weeks and shed in stool for several weeks. Asymptomatic individuals can also shed the virus.

52
New cards

What is the difference between primary and secondary viremia in poliovirus infection?

Primary viremia is usually transient and asymptomatic. Secondary viremia can allow poliovirus to spread to the central nervous system (CNS).

53
New cards

What percentage of poliovirus infections are asymptomatic?

Approximately 75%.

54
New cards

What are the clinical manifestations of poliovirus infection and their approximate frequencies?

  • Asymptomatic infection: 75%

  • Flu-like illness: 25%

  • Meningitis: 1–5%

  • Paralytic poliomyelitis: less than 1%


55
New cards

What is the incubation period and duration of the flu-like illness caused by poliovirus?

Incubation is approximately 3–6 days, and symptoms usually resolve within 2–5 days.

56
New cards

How does poliovirus cause paralytic poliomyelitis?

It replicates in and destroys motor neurons in the spinal cord, brainstem, or motor cortex, resulting in paralysis.

57
New cards

When does paralysis typically develop following poliovirus infection?

Approximately 7–21 days after infection.

58
New cards

What is the mortality rate of paralytic poliomyelitis, and what is a major cause of death?

Approximately 2–10%, often due to respiratory failure caused by paralysis of breathing muscles.

59
New cards

What is post-polio syndrome (PPS)?

A condition that develops years after recovery from poliomyelitis, causing progressive muscle weakness, often affecting previously involved muscle groups.

60
New cards

How long after recovery can post-polio syndrome develop?

Approximately 15–40 years.

61
New cards

What are the characteristic symptoms of post-polio syndrome?

Progressive muscle weakness, muscle and joint pain, muscle atrophy, and potentially severe mobility impairment.

62
New cards

Approximately what percentage of polio survivors develop post-polio syndrome?

Approximately 25–40%

63
New cards

What specimens can be used for poliovirus isolation?

Stool, throat swabs, and cerebrospinal fluid (CSF)

64
New cards

Why is suspected poliovirus infection considered a public health emergency?

Because poliovirus can cause paralysis and spread to others, requiring rapid investigation and measures to prevent transmission.

65
New cards

What was the purpose of the Global Polio Eradication Initiative, and when did it begin?

It began in 1988 to eliminate poliovirus worldwide, when polio was endemic in 125 countries.

66
New cards

How successful have global polio eradication efforts been?

Wild poliovirus infections have decreased by approximately 99%, and wild poliovirus types 2 and 3 have been eliminated.

67
New cards

How did vaccination affect poliomyelitis cases in the United States?

Before vaccination in the 1950s, there were more than 15,000 paralytic cases annually. Following vaccination, cases dropped dramatically to fewer than 10 per year.

68
New cards

What are the two major types of poliovirus vaccines, and who developed them?

  • Inactivated poliovirus vaccine (IPV): Jonas Salk, 1955.

  • Oral poliovirus vaccine (OPV): Albert Sabin, 1962.


69
New cards

What is the main difference between IPV and OPV?

IPV contains inactivated virus, while OPV contains live, attenuated (weakened) virus.

70
New cards

Which poliovirus vaccine has been used exclusively in the United States since 2000?

The inactivated poliovirus vaccine (IPV).

71
New cards

What is the routine childhood IPV vaccination schedule?

Four doses at 2 months, 4 months, 6–18 months, and 4–6 years.

72
New cards

How effective is IPV after three doses?

Approximately 99% effective

73
New cards

What is an important advantage of the oral poliovirus vaccine (OPV)?

It replicates in the gastrointestinal tract, mimicking natural infection and producing intestinal immunity.

74
New cards

What is a major risk associated with OPV?

The weakened virus can undergo genetic changes and become vaccine-derived poliovirus (VDPV), particularly when circulating in underimmunized populations. Live vaccine virus can also be shed in stool.

75
New cards

Who is most commonly infected by human parechoviruses, and how common are infections?

Young children. Approximately 95% are infected by age 5.

76
New cards

What are the typical symptoms of human parechovirus infection, and which patients are at greatest risk of severe disease?

Most infections are asymptomatic or mild, causing fever, runny nose, sore throat, coughing, sneezing, nausea, vomiting, or diarrhea. Newborns and infants younger than 3 months are at greatest risk of meningitis, encephalitis, and seizures.

77
New cards

How are human parechovirus infections diagnosed?

RT-qPCR using CSF, stool, throat swabs, or rectal swabs.

78
New cards

What are the main structural characteristics of Sedoreoviridae?

Non-enveloped RNA viruses with multiple capsid layers (two or three). They have a non-turreted inner capsid.

79
New cards

What is the clinically important human pathogen mentioned in the Sedoreoviridae?

Rotavirus.

80
New cards

What are the genome and envelope characteristics of rotavirus?

Non-enveloped, segmented double-stranded RNA (dsRNA) virus with 11 genome segments.

81
New cards

Which rotavirus species is responsible for most human infections?

Rotavirus A

82
New cards

What is the capsid structure of rotavirus, and what does the virus resemble?

It has multiple capsid layers and resembles a wheel with short spokes.

83
New cards

Why is rotavirus resistant to environmental and gastrointestinal conditions?

Its non-enveloped, multilayered capsid structure provides resistance, allowing it to survive outside the host for several weeks.

84
New cards

How is rotavirus transmitted?

Through the fecal-oral route.

85
New cards

Why is rotavirus highly infectious?

Infected individuals can shed billions of viral particles per gram of stool, facilitating transmission.

86
New cards

During which months does rotavirus typically circulate

January through June.

87
New cards

What is the incubation period of rotavirus?

Approximately 2 days

88
New cards

Which cells does rotavirus infect?

Enterocytes lining the villi of the small intestine

89
New cards

Which age group is most affected by rotavirus?

Children younger than 5 years, especially those younger than 3 years who are most vulnerable to severe gastroenteritis.

90
New cards

What are the major symptoms of rotavirus infection?

Vomiting, watery diarrhea, fever, abdominal pain, anorexia, and dehydration.

91
New cards

How long do rotavirus symptoms typically last?

Approximately 3–8 days.

92
New cards

What are the major complications of severe rotavirus gastroenteritis?

Dehydration and electrolyte imbalances, which may require hospitalization.

93
New cards

Can rotavirus be transmitted when an infected individual has no symptoms?

Yes. Viral shedding can occur before symptoms develop and continue for up to 3 days after symptoms resolve

94
New cards

How does rotavirus infection generally differ between children and adults?

Children may develop mild to severe gastroenteritis, while adults generally experience milder infections.

95
New cards

What laboratory methods are used to diagnose rotavirus infection?

Stool antigen detection using enzyme immunoassay (EIA) or lateral flow testing, and nucleic acid amplification tests (NAAT/PCR).

96
New cards

How common was rotavirus infection among children before vaccination?

Almost all children in the United States had been infected by age 5.

97
New cards

What was the impact of rotavirus in the United States before vaccination?

Among children younger than 5, rotavirus caused more than 400,000 doctor visits, more than 200,000 emergency room visits, 55,000–70,000 hospitalizations, and 20–60 deaths annually.

98
New cards

How did rotavirus epidemiology change following vaccine introduction?

Rotavirus activity developed a biennial pattern, with typically higher incidence in even-numbered years and shorter seasons.

99
New cards

What are the two oral rotavirus vaccines, and how do they differ?

  • RotaTeq (2006): Live attenuated, pentavalent vaccine requiring three doses.

  • Rotarix (2008): Live attenuated, monovalent vaccine requiring two doses.


100
New cards

How effective are RotaTeq and Rotarix?

RotaTeq is approximately 98% effective against severe gastroenteritis, while Rotarix is approximately 85–96% effective.